Pharmaceutical Industry and R&D in Puerto Rico

Ahmad H. Juma’h, Doris Morales-Rodriguez and Antonio Lloréns-Rivera
Additional contact information
Ahmad H. Juma’h: Inter American University of Puerto Rico
Doris Morales-Rodriguez: Inter American University of Puerto Rico
Antonio Lloréns-Rivera: Inter American University of Puerto Rico

Chapter Chapter 6 in Labor Markets and Multinational Enterprises in Puerto Rico, 2015, pp 39-47 from Springer

Abstract: Abstract In today’s advanced technological and competitive era, where globalization takes place, multinational companies expand their competitive advantages to use research and development (R&D). Each market needs to develop new technologies, products, services and processes to face up the economic challenges. The pursuit of competitiveness has led multinational enterprises to develop new strategies to inquire into the key factor for differentiation, using new R&D processes. This chapter discusses R&D and the development of the pharmaceutical industry in Puerto Rico.

Keywords: Competitive Advantage; Pharmaceutical Industry; Manufacturing Sector; Innovation Activity; Generic Drug (search for similar items in EconPapers)
Date: 2015
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:spbchp:978-3-319-17178-4_6

Ordering information: This item can be ordered from
http://www.springer.com/9783319171784

DOI: 10.1007/978-3-319-17178-4_6

Access Statistics for this chapter

More chapters in SpringerBriefs in Economics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().